Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Accro Bioscience raises $50m Series C to advance AC-101 and immune-mediated disease pipeline Ulcerative colitis needs safer oral options. Accro’s OrbiMed-led raise puts RIPK2 inhibition under a bigger clinical spotlight. byPallavi MadhirajuMay 19, 2026